by Raynovich Rod | Sep 21, 2015 | Biopharmaceuticals, Life Science ETF's and Mutual Funds
Update-1… 9/22/15 …Biotech Stocks Trade Down Another Day Biotech stocks were weak tracking NASDAQ which was down 1.5%. The IBB was down 1.49% to $335.40 flat over one month and up 10.57% YTD. The August low was $325 and the IBB is 16% off July 20 highs....
by Raynovich Rod | Feb 10, 2015 | 2024 Rayno Biopharmaceuticals Portfolio, Biopharmaceuticals, Life Science ETF's and Mutual Funds
Energy Stocks Down-Biotech and Healthcare Stocks Are Leaders NASDAQ Up 1.30% 4787 After a few days in the doldrums biotech stocks rallied across the board escaping the drag of macro news. Healthcare and technology sectors were among the leaders of the day moving...
by Raynovich Rod | Feb 4, 2015 | Life Science ETF's and Mutual Funds
Can Healthcare/Biotechnology Funds Outperform ETFs in 2015? In January of 2013 we compared three of the most liquid life science ETFs to some of the top mutual funds in the sector. Review our 2013 summary but the conclusion at that time was that ETFs provided better...
by Raynovich Rod | Dec 4, 2014 | Biopharmaceuticals, Life Science ETF's and Mutual Funds
Update 12/12 Or Maybe NOT!! Jobs data tomorrow and most funds will ride their positions through year end. In the meantime it is a traders market. Update next week but review all our portfolio picks.
by Raynovich Rod | Oct 20, 2014 | Biopharmaceuticals, Clinical Diagnostics and Tools, Life Science ETF's and Mutual Funds
Biotechs Continue To Lead The Market NASDAQ registered its third day of gains up 2.38% for the period and life science stocks followed. The NAZ is now up 3.34% YTD. Biotech stocks are way ahead of the market YTD with our top ETF pick (FBT) up 31% YTD and 3.66% over...
by Raynovich Rod | Sep 24, 2014 | 2023-24 Life Science Portfolios, Biopharmaceuticals
Update-1 …After 1.94% NASDAQ Sell-Off All three market indices got crushed today with a downdraft attributed to ending of QE, rising i rates in 2015, a rising dollar and just plain profit taking. A 3.8% hit on Apple (AAPL) did not help support the QQQ which also...
by Raynovich Rod | Aug 29, 2014 | Biopharmaceuticals, Clinical Diagnostics and Tools, Life Science ETF's and Mutual Funds
As we move into a heavier trading period watch your portfolio for changes as volume picks up. Here are some of our long term portfolio winners where you can take profits: Exact Sciences (EXAS) short squeeze took it to $22. Illumina (ILMN) triple to at $180. Here are a...
by Raynovich Rod | Aug 22, 2014 | 2024 Rayno Biopharmaceuticals Portfolio, Life Science ETF's and Mutual Funds
Large Caps Rule Macro and Seasonal Risks Create a Choppy Market The August biotech rally has taken us to the midpoint of the February top and May bottom and is faltering. Look at the XBI SPDR S&P biotech ETF (XBI), a proxy for momentum and smaller cap trading, up...
by Raynovich Rod | May 14, 2014 | 2024 Rayno Biopharmaceuticals Portfolio, Biopharmaceuticals, Life Science ETF's and Mutual Funds
Update May 30-Fidelity Select Biotech (FBIOX) Fund is lagging Top ETFs FBT and IBB Compared to 2013 when FIDO beat the ETFs it is lagging post February bubble and YTD. It would be difficult to analyze why this happened but my guess is that: FIDO went chasing...
by Raynovich Rod | Apr 15, 2014 | Biopharmaceuticals, Life Science ETF's and Mutual Funds
Update at Close 4/15….. Late Day Reversal To Green The NASDAQ Composite began a rally at 1P EDT and never stopped , moving up 62 points to close at 4034. Biotech ETFs followed step by step to end up in the green after a severe daily decline. The IBB ($217.6) ended up...